Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (20)

2024

  1. Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 9, pp. 1189-1199

  2. SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

    Lupus Science and Medicine, Vol. 11, Núm. 1

2023

  1. Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)

    Seminars in Arthritis and Rheumatism, Vol. 58

  2. Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study

    RMD open, Vol. 9, Núm. 1

  3. Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)

    Seminars in Arthritis and Rheumatism, Vol. 61

2022

  1. Preventing organ damage in systemic lupus erythematosus: the impact of early biological treatment

    Expert Opinion on Biological Therapy, Vol. 22, Núm. 7, pp. 821-829

2021

  1. Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?

    Clinical and Experimental Rheumatology, Vol. 39, Núm. 3, pp. 555-563

2020

  1. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality

    Lupus, Vol. 29, Núm. 12, pp. 1556-1565

2016

  1. Cut-offs and response criteria for the Hospital Universitario la Princesa Index (HUPI) and their comparison to widely-used indices of disease activity in rheumatoid arthritis

    PLoS ONE, Vol. 11, Núm. 9

2015

  1. Cardiovascular events in systemic lupus erythematosus: A Nationwide Study in Spain from the RELESSER Registry

    Medicine (United States), Vol. 94, Núm. 29

2012

  1. Paniculitis facticia y síndrome de Löfgren inducidos por silicona: A propósito de un caso clínico

    Reumatologia Clinica, Vol. 8, Núm. 6, pp. 368-371

2006

  1. Actividad asistencial en las consultas externas de las unidades de reumatología de Galicia

    Reumatologia Clinica, Vol. 2, Núm. 5, pp. 239-246

  2. Desarrollo y validación de un cuestionario de satisfacción con el tratamiento en pacientes con artritis reumatoide

    Reumatologia Clinica, Vol. 2, Núm. 3, pp. 137-145

1999

  1. Clinical images: Histopathologic features of cerebral vasculitis associated with Mycobacterium tuberculosis

    Arthritis and Rheumatism, Vol. 42, Núm. 2, pp. 383

1996

  1. Sjogren syndrome: clinics and ENT diagnosis

    Anales otorrinolaringológicos ibero-americanos, Vol. 23, Núm. 3, pp. 273-283

1995

  1. ESCLERODERMIA LOCALIZADA Y POLIARTRITIS INTERMITENTE

    Revista Espanola de Reumatologia, Vol. 22, Núm. 1, pp. 21-23

  2. ESPONDILITIS ANQUILOSANTE E HIPEROSTOSIS ESTERNOCLAVICULAR CON FIBROSIS RETROPERITONEAL

    Revista Espanola de Reumatologia, Vol. 22, Núm. 1, pp. 17-20

1994

  1. ABSCESOS SUBCUTANEOS TUBERCULOSOS EN PACIENTE CON ARTRITIS REUMATOIDE EN TRATAMIENTO CON METOTREXATO

    Revista Espanola de Reumatologia, Vol. 21, Núm. 9, pp. 350-352

1993

  1. "Sacroiliitis" as the initial manifestation of hepatocarcinoma

    Anales de medicina interna (Madrid, Spain : 1984), Vol. 10, Núm. 3, pp. 135-137

  2. RENDIMIENTO DE LA ECOGRAFIA DE GLANDULAS SALIVALES EN EL SINDROME DE SJOGREN Y SU CONCORDANCIA CON OTRAS PRUEBAS DIAGNOSTICAS

    Revista Espanola de Reumatologia, Vol. 20, Núm. 3, pp. 75-79